When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Infective endocarditis

Last reviewed: 21 Sep 2025
Last updated: 29 Jan 2025

Summary

Definition

História e exame físico

Principais fatores diagnósticos

  • fever/chills
  • night sweats, malaise, fatigue, anorexia, weight loss, myalgias
  • weakness
  • arthralgias
  • headache
  • shortness of breath
  • meningeal signs
  • cardiac murmur
  • Janeway lesions
  • Osler nodes
  • Roth spots
Detalhes completos

Outros fatores diagnósticos

  • splinter hemorrhages
  • cutaneous infarcts
  • chest pain
  • back pain
  • palatal petechiae
Detalhes completos

Fatores de risco

  • prior history of infectious endocarditis
  • presence of artificial prosthetic heart valves
  • certain types of congenital heart disease
  • postheart transplant (patients who develop a cardiac valvulopathy)
  • immunocompromised state
  • presence of cardiac implanted electronic device or intravascular catheters (e.g., for hemodialysis)
  • acquired degenerative valve disease
  • mitral valve prolapse or bicuspid valve prolapse
  • hypertrophic cardiomyopathy
  • intravenous drug use
  • chronic Q fever
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • blood cultures
  • echocardiogram
  • CBC
  • CRP
  • serum chemistry panel with glucose
  • LFTs
  • urinalysis
  • ECG
Detalhes completos

Investigações a serem consideradas

  • rheumatoid factor
  • erythrocyte sedimentation rate
  • complement levels
  • cardiac CT
  • MRI
  • Nuclear imaging and PET
Detalhes completos

Novos exames

  • mean platelet volume (MPV)
  • anti‐beta-2‐glycoprotein I antibodies
  • D-dimer and troponin I

Algoritmo de tratamento

Inicial

suspected infective endocarditis

AGUDA

native valve: confirmed endocarditis

prosthetic valve: confirmed endocarditis

CONTÍNUA

at high risk of infective endocarditis

Colaboradores

Autores

Carl Zehner, MD

Assistant Professor of Medicine

University of Texas MD Anderson Cancer Center

Department of Cardiology

Houston

TX

Declarações

CZ declares that he has no competing interests.

Agradecimentos

Dr Tracey Keteepe-Arachi, Dr Aneil Malhotra, and Dr Michael Papadakis would like to gratefully acknowledge Professor Sanjay Sharma, Dr Jason C. Schultz, Dr Nisha K. Lassi, and Dr Nandan S. Anavekar, previous contributors to this topic.

Declarações

JCS, NKL, NSA, and SS declare that they have no competing interests.

Revisores

Vandana Desai, MD

Professor of Pediatrics

SMIMER Hospital

Gujarat

India

Declarações

VD declares that she has no competing interests.

Lucieni Oliveira Conterno, MD, PhD

Director

Clinical Epidemiology Unit

Marilia Medical School

Sao Paulo

Brazil

Declarações

LOC declares that she has no competing interests.

Andrew Wang, MD

Associate Professor of Medicine

Director, Cardiovascular Disease Fellowship Program

Duke University Medical Center

Durham

NC

Declarações

AW declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86.Texto completo  Resumo

Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042.Texto completo  Resumo

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e72-227.Texto completo

Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021 May 18;143(20):e963-78.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Infective endocarditis images
  • Diagnósticos diferenciais

    • Rheumatic fever
    • Atrial myxoma
    • Libman-Sacks endocarditis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Guidelines for diagnosis and management of infective endocarditis in adults: a WikiGuidelines group consensus statement
    • Guidelines for the management of infective endocarditis
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Endocarditis

    Mais Folhetos informativos para os pacientes
  • Videos

    Venepuncture and phlebotomy: animated demonstration

    How to perform an ECG: animated demonstration

    Mais vídeos
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal